The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)

StatusRecruiting
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion pushed from Mar 2027 to Mar 1, 2029
    • Primary completion date: Mar 2027 to Mar 1, 2027
    • Publications: details revised at 4 of 4 entries
    • Eligibility criteria expanded, about 3 words
  2. Re-verified, no change to tracked fieldsv7
  3. Primary and study completion dates: Mar 2025 to Mar 2027v6
  4. Re-verified, no change to tracked fieldsv5
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Oct 2024 to Oct 1, 2024
    • Site details revised
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Start date: Sep 2024 to Oct 2024v3
  2. Start date: Aug 2024 to Sep 2024v2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
University of Nebraska
110 trials monitored
See 16 trials at risk
COPD
1,120 trials monitored
See 36 trials at risk
Asthma
958 trials monitored
See 36 trials at risk
Investigators are studying how a device called The Lung Master device can help people breathe better. The investigational device increases the amount of air our lungs can hold, which is important for overall lung health. The Lung Master is not approved by the FDA. The study has two visits approximately one month apart. In the first visit participants will take a spirometry test, particularly forced vital capacity (FVC), to measure volume change in the lungs. Participants will take the investigational device home to use daily, either in the morning or evening. Use will be recorded in a diary. After one month, participants will return for another spirometry test. Each study visit will take about one to two hours to complete.
Trial Details
NCT Number NCT06524856
Lead Sponsor University of Nebraska
Conditions
(from sponsor)		 Dyspnea, Chronic Obstructive Pulmonary Disease, Asthma
Related terms Asthma, Dyspnea, Pulmonary Disease, Chronic Obstructive
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov